Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses. From a Danish population-based nationwide cohort of HIV patients we identified the individuals who initiated a salvage regimen including raltegravir and a matched cohort of...

Full description

Bibliographic Details

Published in:	Clinical epidemiology Vol. 2; no. default; pp. 145 - 151
Main Authors:	Engsig, Frederik N, Gerstoft, Jan, Kronborg, Gitte, Larsen, Carsten S, Pedersen, Gitte, Audelin, Anne M, Jørgensen, Louise B, Obel, Niels
Format:	Journal Article
Language:	English
Published:	New Zealand Taylor & Francis Ltd 09.08.2010 Dove Medical Press
Subjects:	Antiretroviral drugs Clinical medicine Epidemiology Immunology Original Research raltegravir matched cohort salvage regime HIV efficacy
ISSN:	1179-1349, 1179-1349
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!